Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
Non-Profit Biotech Calls on the Entire ALS Community to Join a Nationwide Network of Independence Day Events
CAMBRIDGE, Mass., May 18 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced its BBQ For ALS Awareness , is a national initiative designed to increas...
National Ergonomics Conference and Expo Reaches 94% Exhibitor Renewal Rate
New November 17 - 20, 2009 Dates Announced
Ergonomics Programs Prove Vital in a Slow Economy
NEW YORK, March 5 /PRNewswire/ -- The 15th Annual National Ergonomics Conference and Exposition (NECE) will be held at Caesars Palace, Las Vegas, November 17 - 20, 2009. As of today, nearl...
Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials
BOSTON, Jan. 29 /PRNewswire-FirstCall/ -- Perceptive Informatics (Perceptive), the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced that it has reached a key milestone, with 10 million calls placed through it...
Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
NEW YORK, Dec. 11 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary Percutaneous Hepatic Perfusion ("PHP") System for the treatment of cancers of the liver, announced today that the first fifty percent (46 of 92) of patients h...
Covaris Installed Instrument Base Reaches 500 Units
WOBURN, Mass., Nov. 26 /PRNewswire/ -- Covaris Incorporated today
announced that during the summer of 2008, the company celebrated the shipment
of its 500th instrument unit and continued another successful year throughout
2008. To accommodate this rapid business growth, Covaris is both
AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
QUEBEC CITY, Nov. 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on
endocrine therapy and oncology, today reported that it has entered the
second stage of patient recruitment for its Phase 2 trial in endometrial
Tishcon Corp Reaches Donation Milestone Exceeds 1 Million Bottles of Multi-Vitamins for Nourish America
Manufacturer is Pillar of Support for National Children's Program
OJAI, Calif., Oct. 15 /PRNewswire/ -- Raj Chopra CEO and Chief
Scientific Officer of Tishcon Corp and visionary philanthropist easily
recognized the need to support the health of low income children in
America. In January 2000...
Genmab Reaches Milestone in Ofatumumab Collaboration
Summary: Genmab has Reached the Sixth Milestone in its Ofatumumab Collaboration With GSK.
COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S
(OMX: GEN) announced today it has reached the sixth milestone for
ofatumumab (HuMax-CD20(R)) under the terms ...
Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
Summary: Genmab Will Receive a Milestone Payment of Approximately DKK 232.7
Million From GSK for Achievement of Positive Results in the Phase III CLL Study
COPENHAGEN, August 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN)
announced today it has reached the fi...
Migenix averts proxy contest; reaches agreement with DJohnson holdings
VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ - MIGENIX Inc. ("MIGENIX")
announced today that it has reached an agreement with DJohnson Holdings
Inc. ("DJohnson"), a significant shareholder of MIGENIX, that will avoid a
proxy contest at MIGENIX's annual meeting of shareholders scheduled for
Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc.
(TSX:PLI) ("ProMetic") announces today that it has reached an understanding
with a fully integrated, U.S.-based, biotechnology company with respect to
the development and global commercialization of several biopharmaceutical...
AMERIGROUP Reaches Agreement in Principle to Settle Illinois Qui Tam Litigation
VIRGINIA BEACH, Va., July 22 /PRNewswire-FirstCall/ -- AMERIGROUP
Corporation (NYSE: AGP ) announced today that it has reached a comprehensive
settlement agreement in principle that will conclude its civil qui tam
litigation relating to certain marketing practices of the Company's former
Advanced Bionics Reaches Resolution With FDA, Settles Financial Suit
VALENCIA, Calif., July 18 /PRNewswire/ -- Advanced Bionics agreed to
settle an administrative complaint arising from a disagreement with the
U.S. Food and Drug Administration (FDA). The FDA asserted that Advanced
Bionics should have made a formal submission five years ago before using a
Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial
Pivotal Trial in Medullary Thyroid Cancer Planned to Initiate This Summer
SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ --
Exelixis, Inc. (Nasdaq: EXEL ) announced today that the company and the U.S.
Food and Drug Administration (FDA) have reached agreement on the phase 3
PAREXEL Reaches Agreement To Acquire ClinPhone
Combined Capabilities to Create One of the Industry's Largest eClinical Technology Offerings
BOSTON, June 13 /PRNewswire-FirstCall/ -- PAREXEL International
Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services
organization, today announced that the...
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
BioElectronics President, CEO, and Chairman recaps recent investor conference call
FREDERICK, Md., May 22 /PRNewswire-FirstCall/ -- Andrew Whelan,
President and CEO of BioElectronics Corporation (Pink Sheets: BIEL), the
developer of ActiPatch, an FDA-cleared, drug...
Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound.
Direct Medical Systems' Growing Network of Medical Technology Distributors Has Resulted in the First Year of Profitability in 2007.
PLEASANTON, Calif., May 19 /PRNewswire/ -- Direct Medical Systems has
established an office in Russia to open a distribution network covering all
Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR
HILTON HEAD ISLAND, S.C., April 1 /PRNewswire/ -- Dr. Roger Kenneth
Hershline, PhD, MD, the CEO of Global Humanceuticals, Inc. and founder and
chairman of the not-for-profit public charity CureHIV.us, announces today
that he is reaching out to the funder community, including funding
China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
HANGZHOU, China, March 26 /PRNewswire-FirstCall/ -- China Biopharma,
Inc. (OTC Bulletin Board: CBPC) announced today that it has reached
agreement with Beijing Keyuan Xinhai Pharmaceutical Company to launch newly
approved pharmaceutical products made by leading international
R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
WASHINGTON, March 24 /PRNewswire-USNewswire/ -- America's
pharmaceutical and biotechnology research companies invested a record $58.8
billion last year in the research and development of new life-changing
medicines and vaccines -- an increase of nearly $3 billion from 2006,
according to analys...
Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
WASHINGTON and SAN DIEGO, March 17 /PRNewswire/ -- Even as investors
maintain their strong interest in the life sciences sector, industry
stakeholders are facing tough decisions, according to Pillsbury attorneys.
"Despite the current credit crunch in the U.S., life science
Fralex reaches 100th patient milestone in fibromyalgia study
- Interim analysis results expected in Q3 2008 -
TORONTO, March 10 /PRNewswire-FirstCall/ - Fralex Therapeutics Inc.
(TSX:FXI) ("Fralex" or the "Company"), a medical technology company
developing a non-invasive neuromodulation device, today announced the
randomization of the 100th ...
Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
RESEARCH TRIANGLE PARK, N.C., Feb. 20 /PRNewswire/ -- Addrenex
Pharmaceuticals has reached its first milestone accomplishment this year
with the filing of a new drug application (NDA) for its first drug,
CloniBID, to treat hypertension. Upon approval from the Food and Drug
Genmab Reaches Milestones in Ofatumumab Collaboration
Summary: Genmab has Achieved Two Development Milestones in its Ofatumumab Collaboration With GlaxoSmithKline.
COPENHAGEN, January 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN)
announced today it has reached the second and third development milestones
for ofatumumab (HuMax-...
Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone
New Consulting Unit Hosts Three Customer Audits, Continues Growth Strategy That Leverages Pharsight's Industry-Leading Software Tools
MOUNTAIN VIEW, Calif., Dec. 20 /PRNewswire-FirstCall/ -- Pharsight
Corporation (Nasdaq: PHST ), a leading provider of software, strategic
consulting, and ...
Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
AUSTIN, Texas, Oct. 15 /PRNewswire-FirstCall/ -- Luminex Corporation
(Nasdaq: LMNX ) today announced that it has settled the pending litigation
with Rules Based Medicine, Inc ("RBM"). As part of the settlement, Luminex
received a cash payment of $12.5 million. The cash payment was made by RBM...
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
VANCOUVER, Sept. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI , TSX: ANP), announced today that it reached a favourable
agreement with Johnson & Johnson's subsidiary, Conor Medsystems ("Conor")
to settle all outstanding patent litigation with respect to Conor's
Learning how far your message reaches by Googling yourself
CHICAGOIf you buy into the concept that any ink is good ink and if you believe that name and brand recognition is the first step to sales, then its worth a couple minutes a month to Google yourself.
I have a huge media department. Its almost an entire hanging file folder in my office and an ...
Biotech industry reaches midpoint in 50-year maturation cycle
If we assume that the biotech industry started in the late 1970s with the first IPOs taking place in 1980 (Amgen and Cetus), then biotech is already an industry more than 25 years old.
An interesting article in Genetic Engineering News ( GEN ) on March 1 states unequivocally that most indust...
Global information firm reaches diverse markets
Madison, Wis. - Dan Rooney knows soil. He also knows how to build a viable business. And seven years after starting his Madison-based company, his ideas about turning landscape data into packaged products have gone global.
"There is information about location everywhere," said Rooney, founder ...
TomoTherapy's 100th radiology system reaches public sector
Madison, Wis. - TomoTherapy, Inc. has reached the public sector with the sale of its 100 th Hi-Art radiology system.
The Stratton VA Medical Center in Albany, N.Y., a hospital under the U.S. Department of Veterans Affairs , now is treating patients with TomoTherapy's cancer-targeting sys...
Avolte Venture Partners reaches capital goal
Madison, Wis. - Avolte Venture Partners Midwest, a venture capital arm of Boston's Peak Ridge Capital Group, Inc. , says it has reached its initial goal for raising capital and is ready to scout for early-stage investments in Wisconsin and the Midwest.
The fund, which was to be capped at $50 ...
Douglas Stewart reaches distribution pact with digital video firm
Madison, Wis. - The Douglas Stewart Co. has entered into a distribution agreement to offer to its network of education resellers the products of Honestech, Inc. , an Austin, Texas supplier of digital video and Internet Protocol (IP) communication and entertainment products.
Financial terms ...
New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World
...w life is the key to understanding the universe. The Huffington Post is ranked the most powerful (and most widely referenced) blog in the world. It reaches
over 20 million thought-leaders, and has featured celebrity contributors from politics to business and entertainment, including President Barack Obama...
TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
...e two extremely capable public servants and look forward to working with them on the vitally important issues of making sure the power of the Internet reaches
all our citizens and grows our economy."
Mr. Genachowski will bring more than two decades of public and private-sector experience to the Commiss...
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
... regulate angiogenesis, cell metabolism, cell
proliferation, cell death (apoptosis) and cell invasion. HIF-1 alpha protein
is low in normal cells, but reaches
high intracellular concentrations in a
variety of cancers and is strongly correlated with poor prognosis and
resistance to therapy. Enzon is currently...
Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses
severance agreement with unions
SEATTLE, May 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today th...
AutoImmune Inc. Reports 2009 First Quarter Financial Results
...y diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug, dirucotide (formerly referred to as MBP8298), if it reaches
the market. In December 2007, BioMS sublicensed its rights in this product to Eli Lilly and Company. The FDA has granted the product fast track desi...
MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of State's Growing Awareness of Industry's Economic Importance
...the year. Devoted to chronicling the discoveries, trends, issues and personalities that are shaping Michigan's biosciences community, the publication reaches
more than 5000 readers in and out of state.
"We are days away from receipt of the second issue of the magazine. This issue will also contain th...
ChartTrends(R): Bone and Mineral Metabolism in Dialysis Reveals Latest Trends in the Treatment of Calcium, Phosphorus and PTH
...ell as brand persistency.
In the treatment of hyperphosphatemia, patients tend to be initiated on phosphate binder monotherapy when phosphorus reaches
5.7 mg/dL. Phosphorus levels are significantly higher when combination therapy is initiated. Contrary to what Nephrologists perceive based on self-r...